Neutrophil Irg1/itaconate axis protects against experimental colitis by suppressing local inflammation and maintaining hematopoietic homeostasis
Na Zhao, Guojian Wang, Shuang Long, Yin Chen, Jining Gao, Xiaofan Lv, Xinze Ran, Yi Jia, Tao Wang · 2025
Read Neutrophil Irg1/itaconate axis protects against experimental colitis by suppressing local inflammation and maintaining hematopoietic homeostasis by Na Zhao, Guojian Wang, Shuang Long, Yin Chen, Jining Gao, Xiaofan Lv, Xinze Ran, Yi Jia, Tao Wang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12717350.txt.
Description
Na Zhao and co-authors show how a metabolic pathway in neutrophils protects mice against colitis, in work published in 2025. Inflammatory bowel disease involves excessive gut inflammation, and current treatments are unsatisfactory. A gene called Irg1 makes a compound named itaconate that calms inflammation, but its source and mechanism were unclear.
The team found neutrophils in the inflamed colon are the main Irg1 source. Mice lacking Irg1 suffered worse disease, with more weight loss, tissue damage, and neutrophil flooding. Removing neutrophils helped those knockout mice but harmed normal ones, proving the pathway makes neutrophils protective. A cell-permeable form of itaconate reduced colon inflammation and restored blood cell balance. The authors nominate the axis as a treatment target.
Catalog record
| CREATOR | Na Zhao, Guojian Wang, Shuang Long, Yin Chen, Jining Gao, Xiaofan Lv, Xinze Ran, Yi Jia, Tao Wang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |